Safety and utility of acute electroconvulsive therapy for agitation and aggression in dementia

International Journal of Geriatric Psychiatry

Volumn 30, Issue 3, 2015, Pages 265-273

  Acharya, Deepa ^a,b   Harper, David G ^a   Achtyes, Eric D ^c   Seiner, Stephen J ^a   Mahdasian, Jack A ^c   Nykamp, Louis J ^c   Adkison, Lesley ^d   Van White, Lori Der Schuur ^c   McClintock, Shawn M ^e,f   Ujkaj, Manjola ^a   Davidoff, Donald A ^a   Forester, Brent P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d MCLEAN HOSPITAL   (United States)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Aggression; Agitation; Dementia; ECT; Electroconvulsive therapy

Indexed keywords

AGED; AGGRESSION; AGITATION; ARTICLE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; COHEN MANSFIELD AGITATION INVENTORY; CONTROLLED STUDY; CORNELL SCALE FOR DEPRESSION IN DEMENTIA; DEMENTIA; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MALE; MENTAL HEALTH SERVICE; NURSING HOME; REGRESSION ANALYSIS; TREATMENT OUTCOME; ADVERSE EFFECTS; PROCEDURES; PSYCHOLOGY; PSYCHOMOTOR AGITATION; VERY ELDERLY;

PSYCHOTROPIC AGENT;

AGED; AGED, 80 AND OVER; AGGRESSION; DEMENTIA; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MALE; PSYCHOMOTOR AGITATION; PSYCHOTROPIC DRUGS; REGRESSION ANALYSIS;

EID: 84921849546     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.4137     Document Type: Article

References (42)

1. Alexopoulos G, Abrams R, Young R. 1998. The Cornell Scale for Depression in Dementia. Biol Psychiatry 23: 271-284.
2. American psychiatric association. 2000. Diagnostic and Statistical Manual of Mental Disorders 4th edn, Text Revision. American Psychiatry Press: Washington, DC.
3. Baldessarini R. 2012. Chemotherapy in Psychiatry. Springer Verlag: New York.
4. Ballard C, Waite J, Birks J. 2006. Atypical antipsychotics for aggression and psychosis in Alzheimer's disease. Cochrane Database of Systematic Reviews.
5. Bang J, Price D, Prentice G, Campbell J. 2008. ECT treatment for two cases of dementia related pathological yelling. J Neuropsychiatry Clin Neurosci 20(3): 379-380.
6. Bartels S, Horn S, Smout R, et al. 2003. Agitation and depression in frail nursing home elderly patients with dementia: treatment characteristics and service use. Am J Geriatr Psychiatry 11: 231-238.
7. Cohen-Mansfield J. 2009. Agitated behavior in persons with dementia: the relationship between type of behavior, its frequency, and its disruptiveness. J Psychiatric Res 43: 64-69.
8. Cohen-Mansfield J, Marx M, Rosenthal A. 1989. A description of agitation in a nursing home. J Gerontol Med Sci 44(3): M77-M84.
9. Cummings J. 1997. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology 48: S10-S16.
10. Dolder C, Jeste D. 2003. Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high risk patients. Biol Psychiatry 53: 1142-1145.
11. Folstein M, Folstein A, Mchugh P. 1975. Mini mental status exam. J Psychiatric Res 12: 189-198.
12. Galasko D, Bennett D, Sano M, et al. 1997. An inventory to assess activities of daily living for clinical trials in Alzheimer' s disease: the Alzheimer's disease cooperative study. Alzheimer Dis Assoc Disord 11(suppl 2): S33-S39.
13. Gardner D, Murphy A, O 'donnell H, Centorrino F, Baldessarini R. 2010. International consensus study of antipsychotic dosing. Am J Psychiatry 167: 686-693.
14. Gilley D, Bienias J, Wilson R, et al. 2004. Influence of behavioral symptoms on rates of institutionalization for persons with Alzheimer's disease. Psychol Med 34: 1129-1135.
15. Grant J, Mohan S. 2001. Treatment of agitation and aggression in four demented patients using ECT. J ECT 17: 205-209.
16. Guy W. 1976. The Clinical Global Impression Scale. In ECDEU Assessment Manual for Psychopharmacology-Revised. MD: US Dept. of Health, Education and Welfare, ADAMHA, MIMH Psychopharmacology Research Branch: Rockville, MD; 218-222.
17. Hausner L, Damian M, Sartorius A, Frolich L. 2011. Efficacy and cognitive side effects of electroconvulsive therapy (ECT) in depressed elderly inpatients with coexisting mild cognitive impairment or dementia. J Clin Psychiatry 72: 91-97.
18. Hollingworth P, Hamshere M, Moskvina V, et al. 2006. Four components describe behavioral symptoms in 1120 individuals with late-onset Alzheimer's disease. J Amer Geriatr Soc 54: 1348-1354.
19. Janzen S, Zecevic AA, Kloseck M, Orange JB. 2013. Managing agitation using nonpharmacological interventions for seniors with dementia. Am J Alzheimers Dis Other Demen 28(5): 524-532.
20. Kenward M, Roger J. 1997. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 53: 983-997.
21. Kowalchuk R, Keselman H, Algina J, Wolfinger R. 2004. The analysis of repeated measurements with mixed model adjusted F tests. Educ Psychol Measur 64: 224-242.
22. Lyketsos C, Lopez O, Jones B, et al. 2002. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment. JAMA 288: 1475-1483.
23. Mcclintock S, Staub B, Husain M. 2011. The effects of electroconvulsive therapy on neurocognitive function in elderly adults. Ann Long Term Care Clin Care Aging 19: 32-38.
24. Mcdonald W, Thompson T. 2001. Treatment of mania in dementia with electroconvulsive therapy. Psychopharmacol Bull 35: 72-82.
25. Murman D, Chen Q, Powell M, et al. 2002. The incremental direct costs associated with behavioral symptoms in AD. Neurology 59: 1721-1729.
26. Nelson J, Rosenberg D. 1991. ECT treatment of demented elderly patients with major depression: a retrospective study of efficacy and safety. Convuls Ther 7: 157-165.
27. Rao V, Lyketsos C. 2000. The benefits and risks of ECT for patients with primary dementia who also suffer from depression. Int J Geriatr Psychiatry 15: 729-735.
28. Roccaforte W, Wengel S, Burke W. 2000. ECT for screaming in dementia. Am J Geriatr Psychiatry 8: 177.
29. Salzman C, Jeste D, Meyer R, et al. 2008. Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy. J Clin Psychiatry 69: 889-898.
30. Saxton J, Swihart A, Mcgonigle-GibsonKL, Miller VJ, Boller F. 1990. Assessment of the severely impaired patient: description and validation of a new neuropsychological test battery. Psychol Assess 2: 298-303.
31. Schneider LS, Dagerman KS, Insel P. 2005. Risk of death with atypical antipsychotic drug treatment for dementia: meta analysis of randomized placebo controlled trials. JAMA 294: 1934-1943.
32. Stern Y, Tang MX, Albert MS, et al. 1997. Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA 277: 806-812.
33. Stoppe A, Louza M, Rossa M. 2006. Fixed high dose electroconvulsive therapy in the elderly with depression: a double blind, randomized comparison of efficacy and tolerability between unilateral and bilateral electrode placement. J ECT 22: 92-99.
34. Sultzer D, Davis S, Tariot P, et al. 2008. Clinical symptom response to atypical antipsychotic medication in Alzheimer's disease: phase I outcomes from the CATIE-AD effectiveness trial. Amer J Psychiatry 165: 844-854.
35. Sutor B, Rasmussen K. 2008. Electroconvulsive therapy for agitation in Alzheimer disease: a case series. J ECT 24: 239-241.
36. Tew J, Mulsant B, Haskett R. 1999. Acute efficacy of ECT in the treatment of major depression in the old-old. Amer J Psychiatry 156: 1865-1870.
37. Tomac T, Rummans T, Pileggi T, Li H. 1997. Safety and efficacy of electroconvulsive therapy in patients over age 85. Am J Geriatr Psychiatry 5: 126-130.
38. Ujkaj M, Davidoff D, Seiner S, et al. 2010. Safety and ef ficacy of electroconvulsive therapy for the treatment of agitation and aggression in patients with dementia. Am J Geriatr Psychiatry 20: 61-72.
39. US food and drug administration. 2008. Deaths with Antipsychotics in Elderly Patients with Behavioral Disturbances. FDA public health advisory: Washington, DC.
40. Wang P, Schneeweiss S, Avorn J, et al. 2005. Risk of death in elderly users of conventional vs atypical antipsychotic medications. N Engl J Med 353: 2335-2341.
41. Weintraub D, Lippman S. 2001. ECT for major depression and mania with advanced dementia. J ECT 17: 65-67.
42. Zahodne LB, Ornstein K, Cosentino S, Devanand DP, Stern Y. 2013. Longitudinal relationships between Alzheimer disease progression and psychosis, depressed mood, and agitation/agitation. Am J Geriatr Psychiatry S1064-7481(13): 00201-00207.